Company
United StatesPublic company, NASDAQ: PHATPhathom Pharmaceuticals, Inc. (NASDAQ: PHAT), Buffalo Grove, IL – FDA Inspections
Inspection records and compliance data for Phathom Pharmaceuticals, Inc. in Buffalo Grove, IL. 1 FDA inspection on record, 1 Form 483, last inspected July 31, 2026. Publicly traded as NASDAQ: PHAT.
Company Profile
This profile covers Phathom Pharmaceuticals, Inc. based in Buffalo Grove, IL, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected July 31, 2026.
Most cited issue areas
- Failure to submit scientific article1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 31, 2026 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1328784 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Phathom Pharmaceuticals, Inc.
Stock ticker
PHAT
Exchange
NASDAQ
Share price
$6.23
Market cap
$506.4M
Price as of
November 13, 2026
FEI Number
3022958004
Address
2150 E Lake Cook Rd Ste 800, Buffalo Grove, IL 60089-8227, United States
Country
United States
ID: e0db2f80-e368-49ac-839f-282cb240bb58